Alector (ALEC) Operating Expenses (2018 - 2026)
Alector's (ALEC) quarterly Operating Expenses came in at $26.0 million in Q1 2026, down 46.32% year-on-year from $48.4 million in Q1 2025, and down 43.31% on a QoQ basis from $45.8 million in Q4 2025.
Alector (ALEC) Operating Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Operating Expenses data on file, last reported at $26.0 million in Q1 2026.
- On a quarterly basis, Operating Expenses fell 46.32% year-over-year to $26.0 million in Q1 2026; TTM through Mar 2026 was $154.6 million, a 34.0% decrease from a year earlier, with the FY2025 full-year figure at $177.1 million, down 27.9% from the prior year.
- Operating Expenses for Q1 2026 stood at $26.0 million, down from $45.8 million in the prior quarter.
- Over the last five years, Operating Expenses for ALEC reached as high as $70.4 million in Q2 2022 and fell as low as $26.0 million in Q1 2026.
- Historically, Operating Expenses has averaged $57.0 million across 5 years, with a median of $60.7 million in 2024.
- Across the five-year window, Operating Expenses grew 20.89% in 2022 and plunged 46.32% in 2026, its largest moves.
- Year by year, Operating Expenses stood at $69.9 million in 2022, then dropped by 10.35% to $62.6 million in 2023, then decreased by 1.84% to $61.5 million in 2024, then slipped by 25.51% to $45.8 million in 2025, then slumped by 43.31% to $26.0 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $26.0 million in Q1 2026, $45.8 million in Q4 2025, and $40.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Alector | 164.78 Mn | -41.74 Mn | - | 25.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.97 Mn |
| Dec 31, 2025 | 45.80 Mn |
| Sep 30, 2025 | 40.87 Mn |
| Jun 30, 2025 | 42.01 Mn |
| Mar 31, 2025 | 48.37 Mn |
| Dec 31, 2024 | 61.49 Mn |
| Sep 30, 2024 | 63.78 Mn |
| Jun 30, 2024 | 60.69 Mn |
| Mar 31, 2024 | 59.60 Mn |
| Dec 31, 2023 | 62.64 Mn |
| Sep 30, 2023 | 59.69 Mn |
| Jun 30, 2023 | 59.80 Mn |
| Mar 31, 2023 | 66.66 Mn |
| Dec 31, 2022 | 69.88 Mn |
| Sep 30, 2022 | 62.60 Mn |
| Jun 30, 2022 | 70.38 Mn |
| Mar 31, 2022 | 68.60 Mn |
| Dec 31, 2021 | 69.72 Mn |
| Sep 30, 2021 | 56.08 Mn |
| Jun 30, 2021 | 61.89 Mn |